.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Chinese Patent Office
Healthtrust
Teva
UBS
QuintilesIMS
Express Scripts
Novartis
Merck

Generated: June 25, 2017

DrugPatentWatch Database Preview

TRIFLUOPERAZINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Trifluoperazine Hydrochloride, and what generic Trifluoperazine Hydrochloride alternatives are available?

Trifluoperazine Hydrochloride is a drug marketed by Mylan, Watson Labs, Ivax Pharms, Wockhardt, Sandoz, and Duramed Pharms Barr. and is included in twenty NDAs.

The generic ingredient in TRIFLUOPERAZINE HYDROCHLORIDE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.

Summary for Tradename: TRIFLUOPERAZINE HYDROCHLORIDE

Patents:0
Applicants:6
NDAs:20
Suppliers / Packagers: see list8
Bulk Api Vendors: see list80
Clinical Trials: see list2,246
Patent Applications: see list3,938
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIFLUOPERAZINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: TRIFLUOPERAZINE HYDROCHLORIDE

Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
TABLET;ORAL040209-001Jul 7, 1997ABRXNoNo► Subscribe► Subscribe
Duramed Pharms Barr
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
TABLET;ORAL088970-001Apr 23, 1985DISCNNoNo► Subscribe► Subscribe
Sandoz
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
CONCENTRATE;ORAL085787-001Apr 15, 1982DISCNNoNo► Subscribe► Subscribe
Ivax Pharms
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
TABLET;ORAL087613-001Nov 19, 1982DISCNNoNo► Subscribe► Subscribe
Mylan
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride
TABLET;ORAL040209-004Jul 7, 1997ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Deloitte
Federal Trade Commission
US Department of Justice
Novartis
Teva
Daiichi Sankyo
Fuji
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot